Michael Sinclair - 02 Jun 2022 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC.

Role
Director, 10%+ Owner
Signature
/s/ Michael Sinclair
Issuer symbol
N/A
Transactions as of
02 Jun 2022
Net transactions value
-$274,623
Form type
4
Filing time
06 Jun 2022, 16:57:59 UTC
Previous filing
25 Aug 2021
Next filing
08 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Sale $135,136 -9,736 -14% $13.88 59,484 02 Jun 2022 Direct
transaction OPNT Common Stock Sale $139,488 -10,264 -17% $13.59 49,220 03 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.